跳至主要内容
临床试验/NCT01678339
NCT01678339撤回不适用

Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients

AstraZeneca1 个研究点 分布在 1 个国家开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
AstraZeneca
试验地点
1
主要终点
The chronological analysis of the requirements will allow the identification of potential therapeutic combinations or substitutions.

研究概览

简要总结

Thi is an observational, non interventional, cohort analysis by using administrative databases (drugs treatment, laboratory and diagnostic tests, specialist visits and hospitalizations) of Sicilia region to evaluate treatment patterns of patients after Acute Coronary Syndrome (ACS) event.

详细描述

HEALTH-DB ACS

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects discharged alive from hospitalization for ACS

排除标准

  • All patients that don't have a continuative presence as beneficiaries of the region between January 1st, 2007 and December 31st 2011 will be excluded from analysis.

结局指标

主要结局

The chronological analysis of the requirements will allow the identification of potential therapeutic combinations or substitutions.

时间窗: up to 2 years

Adherence to treatment will be calculated in the manner suggested by the literature and used in previous publications. Different methods of assessment will, however, used in order to study the variability of results. The analysis will be conducted over

时间窗: up to 2 years

The diagnostic path for each patient included in the analysis will be described by using all prescription for laboratory test (eg. total cholesterol, LDL cholesterol) and/or diagnostics tests (eg. electrocardiogram) during the observation period.

时间窗: up to 2 years

The drugs treatment path will be described by using all prescriptions of antihypertensive drugs, lipid-lowering drugs and antiplatelet drugs during the observation period.

时间窗: up to 2 years

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验